Merotrax 1 gm/vial (IV Injection or Infusion)
1 gm vial: ৳ 1,300.00
Medicine Details
Category | Details |
---|---|
Generic | Meropenem trihydrate |
Company | Ibn sina pharmaceuticals ltd |
Also available as |
Indications
- Pneumonia
- Nosocomial Pneumonia
- Urinary Tract Infections
- Intra-abdominal Infections
- Gynaecological Infections
- Skin and Skin Structure Infections
- Meningitis
- Septicaemia
- Pulmonary infections in cystic fibrosis
- Empiric treatment for presumed infections in patients with febrile neutropenia
Pharmacology
Bactericidal action by interfering with bacterial cell wall synthesis, potent activity against a broad spectrum of Gram-positive and Gram-negative, aerobic and anaerobic bacteria.
Dosage
- Adults:
- Usual dose 500 mg to 1 gm by intravenous administration every 8 hours
- Dosage varies based on specific infections
- Children:
- Dosage ranging from 10 to 40 mg/kg intravenously every 8 hours
- Specific dosages for different types of infections and patient conditions
Administration
Should be administered by intravenous infusion over approximately 15-30 minutes or as intravenous bolus
Interaction
Competes with Probenecid for active tubular secretion, may reduce serum valproic acid levels
Contraindications
Hypersensitivity to this product
Side Effects
- Inflammation
- Thrombophlebitis
- Pain at the site of injection
- Skin reactions like rash, pruritus, and urticaria
- Abdominal pain
- Nausea
- Vomiting
- Diarrhea
- Headache
Pregnancy & Lactation
Pregnancy Category B, caution during nursing
Precautions & Warnings
- Allergic reaction warrants discontinuation
- Monitoring of liver function in hepatic disease patients
Use in Special Populations
- Renal Impairment: Dosage reduction required for patients with creatinine clearance less than 51 ml/min
- Hepatic Impairment: No dosage adjustments necessary, use with caution in dialysis patients
- Elderly: No dosage adjustments necessary unless creatinine clearance is <51 ml/min
- Children: Efficacy and tolerability in infants under 3 months not established
Overdose Effects
Symptomatic treatment, haemodialysis for subjects with renal impairment if required
Therapeutic Class
Other beta-lactam Antibiotics
Reconstitution
Intravenous solutions preparation, compatibility with various infusion fluids, potency maintenance
Storage Conditions
Store vial below 30°C, away from light and moisture
Related Brands
- Admero 1 gm/vial (IV Injection or Infusion) - ad-din-pharmaceuticals-ltd
- Admero 500 mg/vial (IV Injection or Infusion) - ad-din-pharmaceuticals-ltd
- Merocil 250 mg/vial (IV Injection or Infusion) - pharmacil-limited
- G-Meropenem 1 gm/vial (IV Injection or Infusion) - gonoshasthaya-pharma-ltd
- G-Meropenem 500 mg/vial (IV Injection or Infusion) - gonoshasthaya-pharma-ltd